{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:19Z","timestamp":1791907279721,"version":"4.3.4"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T00:00:00Z","timestamp":1379462400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074453","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T21:16:00Z","timestamp":1379538960000},"page":"e74453","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Leucine-Rich \u03b12-Glycoprotein Is a Novel Biomarker of Neurodegenerative Disease in Human Cerebrospinal Fluid and Causes Neurodegeneration in Mouse Cerebral Cortex"],"prefix":"10.1371","volume":"8","author":[{"given":"Masakazu","family":"Miyajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Kunichika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"H Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u2019s disease: A review of 17 epidemiologic studies","volume":"47","author":"PL McGeer","year":"1996","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer\u2019s disease","volume":"184","author":"MT Heneka","year":"2007","journal-title":"J Neuroimmunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease","volume":"58","author":"H Chen","year":"2005","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"PL McGeer","year":"2007","journal-title":"Neurobiol Aging"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"SC Vlad","year":"2008","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer\u2019s disease","volume":"20","author":"GP Lim","year":"2000","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease","volume":"23","author":"Q Yan","year":"2003","journal-title":"J Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta 1-42 levels in APPV717I transgenic mice","volume":"128","author":"MT Heneka","year":"2005","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1073\/pnas.0806883105","article-title":"Gene expression changes in the course of normal brain aging are sexually dimorphic","volume":"105","author":"NC Berchtold","year":"2008","journal-title":"Proc Natl Sci USA"},{"key":"ref11","first-page":"639","article-title":"[Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author\u2019s transl)]. [Article in German]","volume":"358","author":"H Haupt","year":"1977","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2164-8-124","article-title":"Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors","volume":"8","author":"N Matsushima","year":"2007","journal-title":"BMC Genomics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0959-440X(01)00266-4","article-title":"The leucine-rich repeat as a protein recognition motif","volume":"11","author":"B Kobe","year":"2001","journal-title":"Curr Opin Struct Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.bbrc.2009.03.104","article-title":"Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response","volume":"382","author":"R Shirai","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1373\/clinchem.2013.202937","article-title":"Clinical utility and analytical changes in measurement of cerebrospinal fluid amyloid-\u03b21-42 and \u03c4proteins as Alzheimer disease biomarkers","volume":"59","author":"JH Kang","year":"2013","journal-title":"Clin Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/NEU.0b013e31827414b3","article-title":"Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus","volume":"72","author":"AM Koivisto","year":"2013","journal-title":"Neurosurgery"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00701-011-0963-z","article-title":"Leucine-rich \u03b1-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus","volume":"153","author":"M Nakajima","year":"2011","journal-title":"Acta Neurochir (Wien)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","article-title":"Soluble amyloid precursor protein \u03b1 in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus","volume":"20","author":"M Miyajima","year":"2013","journal-title":"Eur J Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINDS-ADRDA Work Group under the auspices of Department of health and Human Service Task Force on Alzheimer\u2019s disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele: Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"I Litvan","year":"1996","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"H Niwa","year":"1991","journal-title":"Gene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/gene.10008","article-title":"hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo","volume":"31","author":"L Zhuo","year":"2001","journal-title":"Genesis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00701-006-0787-4","article-title":"Analysis of potential diagnostic biomarker in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics","volume":"148","author":"X Li","year":"2006","journal-title":"Acta Neurochir (Wien)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-7091-0923-6_20","article-title":"Brain localization of leucine-rich \u03b12-glycoprotein and its role","volume":"113","author":"M Nakajima","year":"2012","journal-title":"Acta Neurochir Suppl"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutation that cause PARK8-linked Parkinson\u2019s disease","volume":"44","author":"C Pais\u00e1n-Ru\u00edz","year":"2004","journal-title":"Neuron"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"A Zimprich","year":"2004","journal-title":"Neuron"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1002\/ana.20484","article-title":"An LRRK2 mutation as a cause for the parkinsonism in the original Park 8 family","volume":"57","author":"M Funayama","year":"2005","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","article-title":"A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson\u2019s disease","volume":"365","author":"A Di Fonzo","year":"2005","journal-title":"Lancet"},{"key":"ref29","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson\u2019s disease","volume":"365","author":"WP Gilks","year":"2005","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","article-title":"Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations","volume":"76","author":"J Kachergus","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref31","first-page":"410","article-title":"Genetic screening for a single common LRRK2 mutation in familial Parkinson\u2019s disease","volume":"365","author":"WC Nichols","year":"2005","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(05)74809-1","article-title":"LRRK2 mutations and Parkinsonism","volume":"365","author":"M Toft","year":"2005","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson\u2019s disease in North African Arabs","volume":"354","author":"S Lesage","year":"2006","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"JC Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.118919","article-title":"iTAQ-based proteomic identification of leucine-rich \u03b1-2 glycoprotein as a novel inflammatory biomarker in autoimmune disease","volume":"69","author":"S Serada","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"K Imamura","year":"2003","journal-title":"Acta Neuropathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e21519","DOI":"10.1371\/journal.pone.0021519","article-title":"Regulation of LRRK2 expression points to a functional role in human monocyte maturation","volume":"6","author":"J Th\u00e9venet","year":"2011","journal-title":"PLOS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","article-title":"Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures","volume":"118","author":"M Hakimi","year":"2011","journal-title":"J Neural Transm"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is involved in the IFN-gamma response and host response to pathogens","volume":"185","author":"A Gardet","year":"2010","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.neurobiolaging.2009.10.016","article-title":"Transcriptional profile of Parkinson\u2019 blood mononuclear cells with LRRK2 mutation","volume":"32","author":"E Mutez","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ni.2113","article-title":"The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease","volume":"12","author":"Z Liu","year":"2011","journal-title":"Nat Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"MS Moehle","year":"2012","journal-title":"J Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ibd.22936","article-title":"Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis","volume":"18","author":"S Serada","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuron.2009.01.017","article-title":"An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers","volume":"61","author":"MW Linhoff","year":"2009","journal-title":"Neuron"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1523\/JNEUROSCI.0470-10.2010","article-title":"LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development","volume":"30","author":"TJ Siddiqui","year":"2010","journal-title":"J Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1523\/JNEUROSCI.4405-11.2012","article-title":"Cortactin-binding protein 2 modulates the mobility of cortactin and regulates dendritic spine formation and maintenance","volume":"32","author":"YK Chen","year":"2012","journal-title":"J Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jnnp.69.5.705a","article-title":"Diagnostic criteria for corticobasal degeneration","volume":"69","author":"PL Lantos","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T06:10:13Z","timestamp":1563948613000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074453"}},"subtitle":[],"editor":[{"given":"Riqiang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,18]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074453","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,18]]}}}